Skip to main content
SpringerLink
Log in

An Observational Study of Autologous Bone Marrow-Derived Stem Cells Transplantation in Seven Patients with Nervous System Diseases: A 2-Year Follow-Up

  • Translational Biomedical Research
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Currently, autologous bone marrow-derived stem cell is one of the most innovative areas of stem cells research. Previous studies on animal models of nervous system diseases have shown that these cells have a good effect on nervous system disorders. The alternative treatment with stem cells for the nervous system diseases has also gradually reached to clinical application stage. The prospect is captivating, but the safety and efficacy of this procedure need further research. To observe the clinical efficacy and side effects of the treatment for autologous mesenchymal stem cells and neural stem/progenitor cells which are in differentiated form by inducing with cerebrospinal fluid in the patients with nervous system diseases, thirty patients were selected from our hospital (2009-10 to 2012-07) and were followed at 1 month, 3 months, 6 months, 1 year and 2 years after the treatment with autologous mesenchymal stem cells and neural stem/progenitor cells in differentiated form was introduced. In this paper, we will introduce the process to make cells accessible for the clinical application by the description of the changes observed in 7 cases were followed for 2 years. The time for bone marrow mesenchymal stem cells could be available for clinical needs is as early as 5 days, not later than 10 days, and the median time is 8 days, while neural stem/progenitor cells in differentiated form can be available for clinical needs in as early as 12 days, not later than 15 days, and the median time is 13.5 days (statistical explanation: Case 5 only uses autologous mesenchymal stem cells, and Case 7 has two times bone marrow punctures). The neurological function of the patients was improved in 1-month follow-up, and the patients have a better discontinuous trend (statistical explanation: sometimes the neurological function of the patients between two adjacent follow-ups does not change significantly). After transplantation, four patients appeared to have transient fever, but it was easily controlled by symptomatic treatment. Seven patients did not appear to show secondary tumor induced by transplantation of stem cells in 2-year follow-up. Thus, it suggests that the use of autologous bone marrow-derived stem cells transplantation in patients with nervous system diseases is a feasible, convenient, safe, and effective method.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Shevde, N. (2012). Stem cells: Flexible friends. Nature, 483(7387), S22–S26.

    Article  CAS  PubMed  Google Scholar 

  2. Shan, L.-D. (2004). Inducing bone marrow stromal cells to differentiate into nerve cells and using them to treat Parkinson’s disease. Suzhou University.

  3. Zan, K., & Geng, D.-Q. (2009). Treatment of cerebrovascular disease with stem cell transplantation and gene therapy. Chinese Journal of Postgraduates of Medicine, 32(13), 7–9.

    Google Scholar 

  4. Ye, Y., Wan, M. R., & Dai, R. F. (2009). Induction of human bone marrow mesenchymal stem cells differentiation into neural stem/progenitor cells using cerebrospinal fluid. International Journal of Anesthesiology and Resuscitation, 30(5), 394–398.

    Google Scholar 

  5. Ye, Y., Zeng, Y. M., Wan, M. R., & Lu, X. F. (2011). Induction of human bone marrow mesenchymal stem cells differentiation into neural-like cells using cerebrospinal fluid. Cell Biochemistry and Biophysics, 59(3), 179–184.

    Article  CAS  PubMed  Google Scholar 

  6. Chen, L., Xi, H. T., & Huang, H. Y. (2007). Introduction of international cooperative ataxia rating scale. Chinese Journal of Clinical Rehabilitative Tissue Engineering Research, 11(39), 8005–8007.

    Google Scholar 

  7. Huang, H. Y., Chen, L., et al. (2008). Minutes of the first international neural repair society annual meeting. Chinese Journal of Reparative and Reconstructive Surgery, 22(8), 1018–1023.

    Google Scholar 

  8. Heesen, C., Nawrath, L., Reich, C., et al. (2006). Fatigue in multiple sclerosis: An example of cytokine mediated sickness behaviour? Digest of the World Core Medical Journals: Clinical Neurology, 2(5), 44.

    Google Scholar 

  9. Ma, Y. S., Chen, L., Yi, L. K., et al. (2008). Evaluation of comatose patients prognostic using GCS, ICS and APACHE II the three clinical score. Chinese General Practice, 11(19), 1761–1762, 1765.

    Google Scholar 

  10. Huang, H. Y. (2007). Olfactory ensheathing cell transplantation (pp. 69–84, 148–323). Beijing: Science Press.

  11. Jackson, E. L., & Alvarez-Buylla, A. (2008). Characterization of adult neural stem cells and their relation to brain tumors. Cells Tissues Organs, 118(10), 212–224.

    Article  Google Scholar 

  12. Prockop, D. J., Gregory, C. A., & Spees, J. L. (2003). One strategy for cell and gene therapy: Harnessing the power of adult stem cells to repair tissues. Proceedings of the National Academy of Sciences USA, 100(Suppl. 1), 11917–11923.

    Article  CAS  Google Scholar 

  13. de Vasconcelos Dos Santos, A., da Costa Reis, J., Diaz Paredes, B., Moraes, L., Jasmin Giraldi-Guimaraes, A., & Mendez-Otero, R. (2010). Therapeutic window for treatment of cortical ischemia with bone marrow-derived cells in rats. Brain Research, 1306, 149–158.

    Article  CAS  PubMed  Google Scholar 

  14. Hayase, M., Kitada, M., Wakao, S., Itokazu, Y., Nozaki, K., Hashimoto, N., et al. (2009). Committed neural progenitor cells derived from genetically modified bone marrow stromal cells ameliorate deficits in a rat model of stroke. Journal of Cerebral Blood Flow and Metabolism, 29, 1409–1420.

    Article  CAS  PubMed  Google Scholar 

  15. Lee, D. H., Ahn, Y., Kim, S. U., Wang, K. C., Cho, B. K., Phi, J. H., et al. (2009). Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells. Clinical Cancer Research, 15, 4925–4934.

    Article  CAS  PubMed  Google Scholar 

  16. Lee, J. K., Jin, H. K., & Bae, J. S. (2009). Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer’s disease mouse model. Neuroscience Letters, 450, 136–141.

    Article  CAS  PubMed  Google Scholar 

  17. Song, C. H., Honmou, O., Ohsawa, N., Nakamura, K., Hamada, H., Furuoka, H., et al. (2009). Effect of transplantation of bone marrow-derived mesenchymal stem cells on mice infected with prions. Journal of Virology, 83, 5918–5927.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Amano, S., Li, S., Gu, C., Gao, Y., Koizumi, S., Yamamoto, S., et al. (2009). Use of genetically engineered bone marrow-derived mesenchymal stem cells for glioma gene therapy. International Journal of Oncology, 35, 1265–1270.

    CAS  PubMed  Google Scholar 

  19. Venkataramana, N. K., Kumar, S. K., Balaraju, S., Radhakrish-nan, R. C., Bansal, A., Dixit, A., et al. (2010). Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson’s disease. Translational Research, 155, 62–70.

    Article  CAS  PubMed  Google Scholar 

  20. Fleischman, R. A., Simpson, F., Gallardo, T., Jin, X. L., & Perkins, S. (1995). Isolation of endothelial-like stromal cells that express Kit ligand and support in vitro hematopoiesis. Experimental Hematology, 23(13), 1407–1416.

    CAS  PubMed  Google Scholar 

  21. Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., et al. (1999). Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nature Medicine, 5(4), 434–438.

    Article  CAS  PubMed  Google Scholar 

  22. Fukunaga, A., Uchida, K., Hara, K., Kuroshima, Y., & Kawase, T. (1999). Differentiation and angiogenesis of central nervous system stem cells implanted with mesenchyme into ischemic rat brain. Cell Transplantation, 8(4), 435–441.

    CAS  PubMed  Google Scholar 

  23. Berezovskaya, O., Maysinger, D., & Fedoroff, S. (1996). Colony stimulating factor-1 potentiates neuronal survival in cerebral cortex ischemic lesion. Acta Neuropathologica, 92(5), 479–486.

    Article  CAS  PubMed  Google Scholar 

  24. Maestroni, G. J., Cosentino, M., Marino, F., Togni, M., Conti, A., Lecchini, S., et al. (1998). Neural and endogenous catecholamines in the bone marrow. Circadian association of norepinephrine with hematopoiesis? Experimental Hematology, 26(12), 1172–1177.

    CAS  PubMed  Google Scholar 

  25. Eglitis, M. A., Dawson, D., Park, K. W., & Mouradian, M. M. (1999). Targeting of marrow-derived astrocytes to the ischemic brain. NeuroReport, 10(6), 1289–1292.

    Article  CAS  PubMed  Google Scholar 

  26. Zhang, Z. X., Guan, L. X., Zhang, K., Zhang, Q., & Dai, L. J. (2008). A combined procedure to deliver autologous mesenchymal stromal cells to patients with traumatic brain injury. Cytotherapy, 10, 134–139.

    Article  CAS  PubMed  Google Scholar 

  27. Xiong, Y., Mahmood, A., & Chopp, M. (2009). Emerging treatments for traumatic brain injury. Expert Opinion on Emerging Drugs, 14(1), 67–84.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Low, C. B., Liou, Y. C., & Tang, B. L. (2008). Neural differentiation and potential use of stem cells from the human umbilical cord for central nervous system transplantation therapy. Journal of Neuroscience Research, 86(8), 1670–1679.

    Article  CAS  PubMed  Google Scholar 

  29. Kang, X. Q., Zang, W. J., Bao, L., et al. (2006). Differentiating characterization of human umbilical cord blood-derived mesenchymal stem cells in vitro. Cell Biology International, 30(7), 569–575.

    Article  CAS  PubMed  Google Scholar 

  30. Woodbury, D., Schwarz, E. J., Prockop, D. J., et al. (2000). Adult rat and human bone marrow stromal cells differentiate into neurons. Journal of Neuroscience Research, 6(4), 364–370.

    Article  Google Scholar 

  31. Kogter, G., Sensken, S., Airey, J. A., et al. (2004). A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. Journal of Experimental Medicine, 200(2), 123–135.

    Article  Google Scholar 

  32. Yong-zhou, S., Hui-xian, C., Zhe, L., et al. (2008). Effects of brain homogenate on the differentiation of rat bone mesenchymal stem cells into neuron-like cells following traumatic brain injury. Journal of Clinical Rehabilitative Tissue Engineering Research, 12(3), 461–464.

    Google Scholar 

  33. Jia, Y. J., Yang, Y. J., Zhou, Y., et al. (2002). The study of inducing rat bone marrow stromal cells to differentiate into neural cells by using baicalin. Chinese Medical Journal, 82(19), 1337–1341.

    CAS  PubMed  Google Scholar 

  34. Lim, J. Y., Park, S. I., Oh, J. H., et al. (2008). Brain-derived neurotrophic factor stimulates the neural differentiation of human umbilical cord blood-derived mesenchymal stem cells and survival of differentiated cells through MAPK/ERK and P13 K/Akt-dependent signaling pathways. Journal of Neuroscience Research, 86(10), 2168–2178.

    Article  CAS  PubMed  Google Scholar 

  35. Rivera, F. J., Sierraha, W. D., Mingnell, J. J., et al. (2006). Adult hippocampus derived soluble factors induce a neuronal-like phenotype in mesenchymal stem cells. Neuroscience Letters, 406(1–2), 49–54.

    Article  CAS  PubMed  Google Scholar 

  36. Sanchez-Ramos, J., Song, S., Cardozo-Pelaez, F., et al. (2000). Adult bone marrow stromal ceils differentiate into neural cells in vitro. Experimental Neurology, 164, 247–256.

    Article  CAS  PubMed  Google Scholar 

  37. Deng, W., Obrocka, M., Fischer, I., et al. (2001). In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochemical and Biophysical Research Communications, 282, 148–152.

    Article  CAS  PubMed  Google Scholar 

  38. Kim, B. J., Seo, J. H., Bubien, J. K., et al. (2002). Differentiation of adult bone marrow stem cells into neuro progenitor cells in vitro. NeuroReport, 13(9), 1185–1188.

    Article  PubMed  Google Scholar 

  39. Rismanchi, N., Floyd, C. L., Berman, et al. (2003). Cell death and long-term maintenance of neuron-like state after differentiation of rat bone marrow stromal cells: A comparison of protocols. Brain Research, 991, 46–55.

    Article  CAS  PubMed  Google Scholar 

  40. Cao, Z. Y., Liu, H., Shan, J. J., Zhu, M. H., et al. (2011). The alternative-treatment with autologous mesenchymal stem cells for diseases of the nervous system in seven cases. Chinese Journal of Clinical Rehabilitative Tissue Engineering Research, 1, 163–166.

    Google Scholar 

  41. Wang, P. (2009). The study of isolating and culturing of bone marrow mesenchymal stem cells and the influence of cerebrospinal fluid on bone marrow mesenchymal stem cells (pp. 1–55). The graduate thesis of Soochow University (no. 20090501).

  42. Shen, Y. X., Wang, P., Shi, E. D., et al. (2011). Culturing of bone marrow mesenchymal stem cells in vitro with cerebrospinal fluid. Chinese Journal of Clinical Rehabilitative Tissue Engineering Research, 15(36), 6802–6806.

    CAS  Google Scholar 

  43. Yang, H. Y., Gu, R., Wang, W. J., et al. (2009). The cerebrospinal fluid promotes the differentiation of neural stem cells after transplantation of bone marrow mesenchymal stem cells. Chinese Journal of Laboratory Diagnosis, 13(3), 300–302.

    Google Scholar 

  44. Zeng, K. B., Wang, X. F., & Yan, Y. (2003). The effect in growth of bone marrow stromal cells in vitro of cerebrospinal fluid. Chinese Journal of Contemporary Neurology and Neurosurgery, 11(2), 96–99.

    Google Scholar 

  45. Freedman, M. S., & Uccelli, A. (2012). Neurorepair with mesenchymal stem cells: Hope or hype? Lancet Neurology, 11(2), 123–125.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Teaching and Research Section of Neurology, Xuzhou Medical College, Xuzhou, 221002, China

    Chao Ren & Run-lu Geng

  2. Department of Neurology, Affiliated Hospital of Xuzhou Medical College, No. 99 West Huaihai Road, Xuzhou, 221002, Jiangsu, China

    Wei Ge, Hao Chen & De-Qin Geng

  3. Central Laboratory, Affiliated Hospital of Xuzhou Medical College, Xuzhou, 221002, China

    Xiao-Yun Liu & Mei-Rong Wan

Authors
  1. Chao Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Run-lu Geng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wei Ge
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiao-Yun Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hao Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mei-Rong Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. De-Qin Geng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to De-Qin Geng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ren, C., Geng, Rl., Ge, W. et al. An Observational Study of Autologous Bone Marrow-Derived Stem Cells Transplantation in Seven Patients with Nervous System Diseases: A 2-Year Follow-Up. Cell Biochem Biophys 69, 179–187 (2014). https://doi.org/10.1007/s12013-013-9756-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-013-9756-8

Keywords

Search

Navigation